SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | 10-Q: Quarterly report
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
SIGYN THERAPEUTICS INC | 10-K: Annual report
SIGYN THERAPEUTICS INC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Brio Capital Master Fund Ltd.(9.99%),Brio Capital Management LLC(9.99%)
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC: Q3 2023 Earnings Report
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | 10-Q: Q2 2023 Earnings Report
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | 8-K: Current report
SIGYN THERAPEUTICS INC | 10-Q: Q1 2023 Earnings Report
No Data